Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.56
18.12.23
€5.50
18.12.24
-55.90%
04.10.24

Needham & Company LLC 
18.12.23 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€33.60
18.12.23
€118.02
18.12.24
-54.17%
04.10.24

Cantor Fitzgerald 
18.12.23 50%
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.80
18.12.23
€46.66
18.12.24
25.81%
04.10.24

Cantor Fitzgerald 
18.12.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€9.24
18.12.23
€11.90
18.12.24
72.62%
04.10.24

HSBC Holdings plc 
18.12.23 50%
sell
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.85
18.12.23
-
18.12.24
-9.20%
04.10.24

HSBC Holdings plc 
18.12.23 50%
sell
Affimed N.V.

Start price
Target price
Perf. (%)
€0.37
17.12.23
-
17.12.24
49.46%
08.03.24

StockNews.com 
17.12.23 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
17.12.23
-
17.12.24
-
19.09.23

StockNews.com 
17.12.23 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1.90
16.12.23
-
16.12.24
-1.68%
02.05.24

StockNews.com 
16.12.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.56
16.12.23
-
16.12.24
-66.20%
12.08.24

StockNews.com 
16.12.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€170.20
15.12.23
€362.53
15.12.24
43.42%
04.10.24

HC Wainwright 
15.12.23 50%
buy
Icon plc

Start price
Target price
Perf. (%)
€255.70
15.12.23
€326.90
15.12.24
4.54%
04.10.24

Truist Financial Co. 
15.12.23 50%
buy
Elanco Animal Health Inc.

Start price
Target price
Perf. (%)
€13.04
15.12.23
€14.65
15.12.24
0.51%
01.10.24

Morgan Stanley 
15.12.23 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€21.58
15.12.23
€28.39
15.12.24
10.98%
03.10.24

Citigroup Inc. 
15.12.23 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€5.22
15.12.23
-
15.12.24
56.32%
31.01.24

Saftman 
15.12.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€23.80
14.12.23
€32.76
14.12.24
14.28%
04.10.24

Truist Financial Co. 
14.12.23 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€364.55
14.12.23
€345.72
14.12.24
13.77%
04.10.24

Cantor Fitzgerald 
14.12.23 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€25.60
14.12.23
€38.21
14.12.24
-45.14%
27.09.24

Cantor Fitzgerald 
14.12.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€59.40
14.12.23
€91.89
14.12.24
11.95%
04.10.24

Cantor Fitzgerald 
14.12.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€169.60
14.12.23
€197.08
14.12.24
43.93%
04.10.24

Piper Sandler 
14.12.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€235.40
14.12.23
€262.00
14.12.24
-28.14%
04.10.24

Stifel Nicolaus 
14.12.23 50%
buy
Exact Sciences

Start price
Target price
Perf. (%)
€65.00
14.12.23
€82.22
14.12.24
-4.18%
04.10.24

Guggenheim 
14.12.23 50%
buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€10.20
14.12.23
€18.27
14.12.24
-64.31%
04.10.24

Wells Fargo & Company 
14.12.23 50%
buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.56
14.12.23
€2.74
14.12.24
-26.13%
21.03.24

HC Wainwright 
14.12.23 50%